Skip to NavigationSkip to content

Iran reveals plans to domestically produce 135 strategic drugs

Published on 26/09/19 at 11:24am
Image Credit:

Iran has announced plans to promote self-sufficiency within the country with regard to its medicines production, with an aim of producing 135 strategic pharmaceutical products within its borders.

According to the Information Center of Iran’s National Elites Foundation, the nation’s Vice President for Science and Technology Affairs, Sorena Sattari, was quoted as saying:  “We have initiated the programme of self-efficacy in drug production since last year. In this regard, 27 biological drugs, 50 chemical drugs, and 58 raw materials that generate the foreign currency drain will be created in Iran with the help of knowledge-based companies and start-ups.”

This could provide an alternative, cheaper means of production to the “foreign currency drain” of $570 million that the country spends currently on these products.

Sattari added: “One of the steps taken by the Vice Presidency in support of domestic producers is realisation of customs exemptions. We have aimed to introduce effective exemptions to contribute to the development of companies and production of new and innovative products.”

Sattari was present at the fifth Iran Pharma Expo alongside the country’s Minister of Health, Head of Food and Drug Organization, and Economic Deputy Minister of Foreign Affairs at the Imam Khomeini Musalla in Tehran. The event was attended by over 400 domestic and 150 foreign companies.

Matt Fellows

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches